Caitong International Asset Management »

China Sxt Pharmaceuticals In shares owned by Caitong International Asset Management

Quarter-by-quarter ownership of China Sxt Pharmaceuticals In shares owned by Caitong International Asset Management from 13F filings

Historical chart of Caitong International Asset Management investment in China Sxt Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including China Sxt Pharmaceuticals In held by Caitong International Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in China Sxt Pharmaceuticals In by Caitong International Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2 1 2.00

More positions owned by Caitong International Asset Management

Lumentum Hldgs (LITE)
Axt (AXTI)
Venture Global Com Cl A (VG)
Marvell Technology (MRVL)
Palantir Technologies Cl A (PLTR)
Petroleo Brasileiro S A Sponsored Adr (PBR)
Exxon Mobil Corporation (XOM)
CF Industries Holdings (CF)
Cheniere Energy Com New (LNG)
Petroleo Brasileiro S A Sp Adr Non Vtg (PBR.A)
Lam Research Corp Com New (LRCX)
Chevron Corporation (CVX)
SLB Com Stk (SLB)
Visa Com Cl A (V)
Apple (AAPL)

View all positions for Caitong International Asset Management

Top funds holding China Sxt Pharmaceuticals In

Sabby Management
Royal Bank of Canada
UBS Group
Caitong International Asset Management

View all funds holding China Sxt Pharmaceuticals In